Scholarlink

<p>Bone fractures present significant surgical and healthcare challenges and require innovative bone regeneration strategies. Current research explores selenium (Se)-enhanced polycaprolactone (PCL) scaffolds for improved defect repair. Selenium, known for its antioxidant, anti-inflammatory, and osteogenic properties, was integrated into 3D-printed PCL scaffolds to create customized implants for precise fracture filling. PCL-Se scaffolds were characterized via SEM–EDS, FTIR, ICP, SEM, and wettability tests, confirming that Se incorporation increased hydrophilicity and enabled controlled, nontoxic Se release. In vitro experiments with rat bone marrow mesenchymal stem cells (rBMSCs) demonstrated enhanced osteogenic differentiation on PCL-Se scaffolds, with higher alkaline phosphatase activity, calcium deposition and upregulated osteogenic gene expression than those on neat PCL. In vivo testing of critical-sized femoral defects in Wistar rats revealed superior bone regeneration with PCL-Se implants, which was validated via micro-CT and histopathology. The scaffolds promoted greater new bone formation, suggesting the role of Se in stimulating remodeling. These findings highlight the potential of PCL-Se as a bioactive, biodegradable solution for osteoporotic fracture repair, combining structural precision with biochemical cues to address regenerative challenges. By improving scaffold functionality and osteogenesis, this approach could reduce complications in bone defect reconstruction, offering a promising strategy for aging populations and osteoporosis-related fractures. However, further clinical studies are needed to translate these advancements into practical surgical applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Selenium-containing polycaprolactone 3D-printed scaffold for osteogenesis enhancement and bone healing

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月3日

查看全文
  • Latifeh Karimzadeh Bardeei,
  • Fakhrossadat Tabatabaee,
  • Amirreza Afazalifar,
  • Hanieh Jalali,
  • Jochen Salber

摘要

Bone fractures present significant surgical and healthcare challenges and require innovative bone regeneration strategies. Current research explores selenium (Se)-enhanced polycaprolactone (PCL) scaffolds for improved defect repair. Selenium, known for its antioxidant, anti-inflammatory, and osteogenic properties, was integrated into 3D-printed PCL scaffolds to create customized implants for precise fracture filling. PCL-Se scaffolds were characterized via SEM–EDS, FTIR, ICP, SEM, and wettability tests, confirming that Se incorporation increased hydrophilicity and enabled controlled, nontoxic Se release. In vitro experiments with rat bone marrow mesenchymal stem cells (rBMSCs) demonstrated enhanced osteogenic differentiation on PCL-Se scaffolds, with higher alkaline phosphatase activity, calcium deposition and upregulated osteogenic gene expression than those on neat PCL. In vivo testing of critical-sized femoral defects in Wistar rats revealed superior bone regeneration with PCL-Se implants, which was validated via micro-CT and histopathology. The scaffolds promoted greater new bone formation, suggesting the role of Se in stimulating remodeling. These findings highlight the potential of PCL-Se as a bioactive, biodegradable solution for osteoporotic fracture repair, combining structural precision with biochemical cues to address regenerative challenges. By improving scaffold functionality and osteogenesis, this approach could reduce complications in bone defect reconstruction, offering a promising strategy for aging populations and osteoporosis-related fractures. However, further clinical studies are needed to translate these advancements into practical surgical applications.